SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C116 - Multiple Sclerosis Therapy: Symptom Management

Event Time: Tuesday April 25, 2017 7:00 am to 9:00 am
Topic(s): MS and CNS Inflammatory Disease
Director(s): Jonathan Carter MD
Description: Symptom management in MS remains a very important determinant of quality of life in MS patients, even with the advent of increasing numbers of MS disease-modifying therapies. Symptoms of MS may be under-recognized and there are knowledge gaps among neurologists regarding management of these common symptoms. Faculty will review the management of common MS symptoms including spasticity, fatigue, gait disorders, bladder problems, bowel problems, and sexual dysfunction, and conclude with a panel discussion regarding management of these and other commonly encountered symptoms in MS patients. This program complements C36: Multiple Sclerosis Therapy: Disease-modifying Treatment I and C54: Multiple Sclerosis Therapy: Disease-modifying Treatment II, but covers independent topics.
Completion Message: Participants should be able to diagnose and treat symptoms of fatigue, sleep disorders, spasticity, gait difficulties, bladder and bowel symptoms, and sexual dysfunction in MS patients.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Program Speakers - Tentative

Start/End Time Title Faculty
7:00 AM - 7:30 AM Management of Fatigue, Sleep Disorders, and Spasticity in MS Jonathan Carter MD 
7:30 AM - 8:00 AM Management of Ambulatory Dysfunction in MS Michelle Cameron MD 
8:00 AM - 8:30 AM Management of GU Dysfunction: When MS Hits Below the Belt Barbara Giesser MD, FAAN 
8:30 AM - 9:00 AM Case-Based Panel Discussion: MS Symptom Management Faculty 

Disclosures

Speaker Disclosure
Michelle Cameron, MD Dr. Cameron has received personal compensation for activities with ReWalk and Adamas as a consultant.

Jonathan L. Carter, MD Dr. Carter received personal compensation from Alder Pharmaceuticals Inc., for serving as a member of a Data Safety Monitoring Committee for a migraine clinical trial. Dr. Carter received personal compensation from the Global Academy for Medical Education for CME activities as a course co-director and speaker for the Summit in Neurology and Psychiatry CME course, and for preparing a MS Drug Monograph for Omnicare, Inc. Dr. Carter has received research support from Sanofi, Genzyme, and Roche.

Barbara S. Giesser, MD, FAAN Dr. Giesser has nothing to disclose.

Register Now

Related Courses

Saturday April 21, 2018

9:30 AM-11:30 AM
C11 Treatment of Pediatric Multiple Sclerosis in the Current Era Brenda Banwell MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C33 Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making Aaron Miller MD, FAAN
3:30 PM-5:30 PM
C57 Spanish: Update on MS Therapy Lilyana Amezcua MD

Tuesday April 24, 2018

7:00 AM-9:00 AM
C98 Multiple Sclerosis Overview I: Clinical Pearls John Corboy MD, FAAN
1:00 PM-3:00 PM
C108 Multiple Sclerosis Overview II: Clinical Advances Scott Newsome DO, FAAN
3:30 PM-5:30 PM
C122 Multiple Sclerosis Overview III: Basic and Translational Science Michael Racke MD

Wednesday April 25, 2018

7:00 AM-9:00 AM
C136 Multiple Sclerosis Therapy: Disease-modifying Treatment I David Jones MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C147 Multiple Sclerosis Therapy: Disease-modifying Treatment II John Rose MD, FAAN
3:30 PM-5:30 PM
C162 Multiple Sclerosis Therapy: Symptom Management Jonathan Carter MD

Thursday April 26, 2018

7:00 AM-9:00 AM
C175 Clinical Pearls in Autoimmune Neurology: Real World Cases Stacey Clardy MD, PhD
1:00 PM-3:00 PM
N5 Neuroscience in the Clinic: Treatment of Progressive Multiple Sclerosis Eric Klawiter MD,
Ellen Mowry MD, FAAN

Friday April 27, 2018

1:00 PM-3:00 PM
C224 Neuromyelitis Optica Spectrum Disorders Dean Wingerchuk MD, FAAN

MEMBER LOG IN

Forgot Password?